Sensorion (ALSEN) EUR0.1

Sell:€0.30Buy:€0.33€0.04 (13.01%)

Prices delayed by at least 15 minutes
Sell:€0.30
Buy:€0.33
Change:€0.04 (13.01%)
Deal now
Prices delayed by at least 15 minutes
Sell:€0.30
Buy:€0.33
Change:€0.04 (13.01%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Sensorion SA is a France-based company principally engaged in the biopharmaceutical sector. The Company is principally active in the development of targeted therapeutic solutions to treat inner ear diseases. The Company develops also drug treatments, from molecular biology all the way to animal pharmacology, toxicology, and clinical research and therapeutic solutions to treat vestibular deficits. Sensorion SA is a spin-off of the research team Pathophysiology and Therapy of Vestibular Deficits in Montpellier Neuroscience Institute.

Key people

Amit Munshi
Independent Chairman of the Board
Nawal Ouzren
Chief Executive Officer, Director
Laurene Danon
Chief Financial Officer
Bernd Schmidt
Chief Technical Officer
Geraldine Honnet
Chief Medical Officer
Khalil Z. Barrage
Director
Natalie Berner
Director - Representative of Redmile Group
Julien Miara
Director - Representative of Invus
Cedric Moreau
Director - Representing Sofinnova Partners
Federico Mingozzi
Non-Executive Director
Click to see more

Key facts

  • EPIC
    ALSEN
  • Location
    France
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    FR0012596468
  • Market cap
    €87.79m
  • Employees
    63
  • Shares in issue
    300.50m
  • Exchange
    Euronext Paris
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.